Search Results 2641-2650 of 18305 for rheumatoid arthritis

1. mRNA transfection improves CTL response in immunotherapy - Mayo Clinic

   The study also showed that transcription factor ETS1 played a role in regulating the activity of NKG7 . All of these results show that NKG7 is a necessary ...

2. Scoliosis - Doctors and departments - Mayo Clinic

   n, Arthritis, Neck pain, Scoliosis, Spondylosis, Cervical radiculopathy, Lumbar pain, Cervical herniated disk, Lumbar radiculopathy, Facet joint syndrome ...

3. Mayo Clinic Minute: How vasculitis affects the body

   What is vasculitis and how does it affect the body? Learn more from Mayo Clinic expert, Dr. Kenneth Warrington.

4. Cholangiocarcinoma Clinical Trials - Mayo Clinic Research

   ... factor receptor 2 (FGFR2). Ponatinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth ...

5. A Study to Assess Force Feedback with the SoftHand Pro - Mayo Clinic

   Orthopedic, joint degeneration (i.e., arthritis, verified by x-ray) affecting the hand or cervical spine that severely limit upper limb function. Visual ...

6. Development of Technologies to Increase In-Seat Movement to Prevent Sitting- Acquired Pressure Injuries in Wheelchair Users - Mayo Clinic

   They have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence.

7. Quick Quiz: Women's Heart Health - Mayo Clinic News Network

   False. Unfortunately, all the salads and yoga in the world can't eliminate your heart disease risk. Family history often plays a factor. You easily can be ...

8. Minnesota Regional Spinal Cord Injury Model Systems (SCIMS) program designation fuels new research aimed at improving patient outcomes - Mayo Clinic

   Evaluating the utility of spasticity and brain-derived neurotrophic factor in predicting neurological and functional recovery after SCI; Aging well with ...

9. Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC). - Mayo Clinic

   ... factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) wild-type locally advanced or metastatic NSCLC. Participation eligibility. Participant eligibility ...

10. Patient Experience with Treatment and Self-care Clinical Tool: Patient and Healthcare Provider Discussion Groups - Mayo Clinic

    Diagnosed with 2 or more conditions from a pre-specified list of 20 chronic conditions (e.g., selected cancer types, arthritis, COPD, hypertension). Able to ...